LLY vs. REVG

Last updated Jun 9, 2026

LLY (Eli Lilly and Company) and REVG (REV Group, Inc.) are both stocks. LLY operates in Drug Manufacturers - General (Healthcare), while REVG operates in Farm & Heavy Construction Machinery (Industrials). Over the past 5 years, LLY returned 39.75%/yr vs 32.82%/yr for REVG. At a 0.10 correlation, their price movements are largely independent.

Performance

LLY vs. REVG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eli Lilly and Company (LLY) and REV Group, Inc. (REVG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LLY achieves a 7.29% return, which is significantly higher than REVG's 5.08% return.

LLY

• 1D: 1.57%
• 1M: 21.37%
• YTD: 7.29%
• 6M: 15.58%
• 1Y: 50.32%
• 3Y*: 38.07%
• 5Y*: 39.75%
• 10Y*: 33.71%

REVG

• 1D: 0.00%
• 1M: 0.00%
• YTD: 5.08%
• 6M: 14.67%
• 1Y: 43.05%
• 3Y*: 89.79%
• 5Y*: 32.82%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LLY vs. REVG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LLY Eli Lilly and Company	7.29%	40.25%	33.30%	60.91%	34.26%	66.08%	31.04%	16.14%	40.45%	16.21%
REVG REV Group, Inc.	5.08%	91.79%	108.93%	46.01%	-9.35%	62.15%	-26.83%	65.71%	-76.63%	27.02%

Correlation

The correlation between LLY and REVG is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.12
Correlation (All Time) Calculated using the full available price history since Jan 27, 2017	0.10

Fundamentals

Market Cap LLY : $1.03T REVG : $3.15B
EPS LLY : $28.14 REVG : $1.93
PE Ratio LLY : 40.83 REVG : 33.05
PEG Ratio LLY : 0.82 REVG : 0.22
PS Ratio LLY : 14.28 REVG : 1.28
PB Ratio LLY : 33.00 REVG : 7.57
Total Revenue (TTM) LLY : $72.25B REVG : $2.46B
Gross Profit (TTM) LLY : $59.75B REVG : $369.80M
EBITDA (TTM) LLY : $32.97B REVG : $168.60M

Return for Risk

LLY vs. REVG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LLY

LLY Risk / Return Rank: 77
LLY Sharpe Ratio Rank: 79
LLY Sortino Ratio Rank: 74
LLY Omega Ratio Rank: 76
LLY Calmar Ratio Rank: 77
LLY Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LLY vs. REVG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and REV Group, Inc. (REVG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LLY	REVG	Difference
Sharpe ratio: Return per unit of total volatility	1.33	1.74	-0.41
Sortino ratio: Return per unit of downside risk	1.90	2.55	-0.64
Omega ratio: Gain probability vs. loss probability	1.26	1.40	-0.14
Calmar ratio: Return relative to maximum drawdown	2.14	2.20	-0.06
Martin ratio: Return relative to average drawdown	5.32	6.08	-0.76
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LLY vs. REVG - Sharpe Ratio Comparison

The current LLY Sharpe Ratio is 1.33, which is comparable to the REVG Sharpe Ratio of 1.74. The chart below compares the historical Sharpe Ratios of LLY and REVG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LLY	REVG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.33	1.74	-0.41
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	1.23	0.76	+0.47
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	1.12	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.58	0.27	+0.31

Drawdowns

LLY vs. REVG - Drawdown Comparison

The maximum LLY drawdown since its inception was -68.24%, smaller than the maximum REVG drawdown of -88.07%. Use the drawdown chart below to compare losses from any high point for LLY and REVG.

Drawdown Indicators

	LLY	REVG	Difference
Max Drawdown Largest peak-to-trough decline	-68.24%	-88.07%	+19.83%
Max Drawdown (1Y) Largest decline over 1 year	-23.64%	-23.48%	-0.16%
Max Drawdown (3Y) Largest decline over 3 years	-34.48%	-23.48%	-11.00%
Max Drawdown (5Y) Largest decline over 5 years	-34.48%	-43.74%	+9.26%
Max Drawdown (10Y) Largest decline over 10 years	-34.48%	—	—
Current Drawdown Current decline from peak	0.00%	-7.32%	+7.32%
Average Drawdown Average peak-to-trough decline	-19.22%	-40.91%	+21.69%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.49%	8.34%	+1.15%

Volatility

LLY vs. REVG - Volatility Comparison

Eli Lilly and Company (LLY) has a higher volatility of 9.55% compared to REV Group, Inc. (REVG) at 0.00%. This indicates that LLY's price experiences larger fluctuations and is considered to be riskier than REVG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LLY	REVG	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.55%	0.00%	+9.55%
Volatility (6M) Calculated over the trailing 6-month period	27.05%	13.38%	+13.67%
Volatility (1Y) Calculated over the trailing 1-year period	38.16%	29.72%	+8.44%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.54%	43.95%	-11.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	30.18%	51.58%	-21.40%

Dividends

LLY vs. REVG - Dividend Comparison

LLY's dividend yield for the trailing twelve months is around 0.56%, while REVG has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LLY Eli Lilly and Company	0.56%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%
REVG REV Group, Inc.	0.28%	0.39%	10.07%	1.10%	1.58%	1.06%	1.14%	1.64%	2.66%	0.46%	0.00%	0.00%

Financials

LLY vs. REVG - Profitability Comparison

The chart below illustrates the profitability comparison between Eli Lilly and Company and REV Group, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

REVG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, REV Group, Inc. reported a gross profit of 102.60M and revenue of 664.40M. Therefore, the gross margin over that period was 15.4%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

REVG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, REV Group, Inc. reported an operating income of 57.60M and revenue of 664.40M, resulting in an operating margin of 8.7%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.

REVG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, REV Group, Inc. reported a net income of 28.90M and revenue of 664.40M, resulting in a net margin of 4.4%.

Frequently Asked Questions

Can I hold both LLY and REVG in my portfolio?

LLY and REVG have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LLY or REVG?

LLY has higher volatility (9.55%) compared to REVG (0.00%). In terms of maximum drawdown, LLY dropped -68.24% vs REVG's -88.07%.

Which has better risk-adjusted returns?

REVG currently has the higher Sharpe Ratio (1.74 vs 1.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.